Evidence map›Paper›PMID 25613364›Full record

ArticleEuropean journal of cell biology2015

Profilin1 regulates invadopodium maturation in human breast cancer cells.

A Valenzuela-Iglesias, V P Sharma, B T Beaty, Z Ding, L E Gutierrez-Millan, P Roy, J S Condeelis, J J Bravo-Cordero

Open access · greenAbstract read
In one paragraph

Article in European journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The phospholipid PI(3,4)PNature communications · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

A Valenzuela-IglesiasDepartment of Scientific and Technological Research DICTUS, University of Sonora, Hermosillo, Mexico. Electronic address: a.valenzuela.iglesias@gmail.com.
V P SharmaDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States; Gruss Lipper Biophotonics Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States.
B T BeatyDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States.
Z DingDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
L E Gutierrez-MillanDepartment of Scientific and Technological Research DICTUS, University of Sonora, Hermosillo, Mexico.
P RoyDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, United States.
J S CondeelisDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States; Gruss Lipper Biophotonics Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States. Electronic address: john.condeelis@einstein.yu.edu.
J J Bravo-CorderoDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States; Gruss Lipper Biophotonics Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, United States. Electronic address: jose-javier.bravo@einstein.yu.edu.
Albert Einstein College of Medicine · USUniversidad de Sonora · MXUniversity of Pittsburgh · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
Signal transduction regulating tumor cell disseminationR01CA150344 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CONDEELIS, JOHN S · 2010 to 2020
$3.7M
Profilin as a target to suppress Invasive breast cancerR01CA108607 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROY, PARTHA · 2006 to 2017
$2.6M
NCI NIH HHS 2R01 CA108607NCI NIH HHS CA150344NCI NIH HHS P01 CA100324NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA108607NCI NIH HHS R01 CA150344NIGMS NIH HHS T32-GM007288
6 · The paper itself

Abstract

Invadopodia are actin-driven membrane protrusions that show oscillatory assembly and disassembly causing matrix degradation to support invasion and dissemination of cancer cells in vitro and in vivo. Profilin1, an actin and phosphoinositide binding protein, is downregulated in several adenocarcinomas and it is been shown that its depletion enhances invasiveness and motility of breast cancer cells by increasing PI(3,4)P2 levels at the leading edge. In this study, we show for the first time that depletion of profilin1 leads to an increase in the number of mature invadopodia and these assemble and disassemble more rapidly than in control cells. Previous work by Sharma et al. (2013a), has shown that the binding of the protein Tks5 with PI(3,4)P2 confers stability to the invadopodium precursor causing it to mature into a degradation-competent structure. We found that loss of profilin1 expression increases the levels of PI(3,4)P2 at the invadopodium and as a result, enhances recruitment of the interacting adaptor Tks5. The increased PI(3,4)P2-Tks5 interaction accelerates the rate of invadopodium anchorage, maturation, and turnover. Our results indicate that profilin1 acts as a molecular regulator of the levels of PI(3,4)P2 and Tks5 recruitment in invadopodia to control the invasion efficiency of invadopodia.

Indexed as

ActinsAdaptor Proteins, Vesicular TransportBreast NeoplasmsCell Membrane StructuresExtracellular MatrixHumansPhosphatidylinositolsProfilinsActinsAdaptor Proteins, Vesicular TransportPFN1 protein, humanPFN2 protein, humanPhosphatidylinositolsProfilinsSH3PXD2A protein, humanMatrix degradationPI(3,4)P(2)Profilin1Tks5

Identifiers

PMID25613364
PMCPMC4322761
OpenAlexW2012745859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.